sec whistleblower attorneys
September 27, 2019
Mylan N.V.
Financial Fraud
SANCTION AMOUNT: $30000000
Defendants: Mylan N.V.
Pharmaceutical company agreed to settle charges of accounting and disclosure failures relating to a Department of Justice probe into whether it overcharged Medicaid by hundreds of millions of dollars for EpiPen, its largest revenue and profit generating product.
- Key Docs
- Official SEC press release
